Principal Financial Group Inc. Sells 84,342 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Principal Financial Group Inc. decreased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 2.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,252,337 shares of the company's stock after selling 84,342 shares during the quarter. Principal Financial Group Inc. owned 2.71% of Privia Health Group worth $59,225,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently made changes to their positions in PRVA. Canada Pension Plan Investment Board acquired a new stake in Privia Health Group in the second quarter valued at approximately $26,000. Nisa Investment Advisors LLC boosted its position in Privia Health Group by 107.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company's stock worth $31,000 after buying an additional 930 shares during the period. GAMMA Investing LLC grew its holdings in Privia Health Group by 98.7% during the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company's stock worth $31,000 after acquiring an additional 845 shares during the last quarter. Signaturefd LLC increased its position in Privia Health Group by 46.3% in the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company's stock valued at $34,000 after acquiring an additional 626 shares during the period. Finally, Quarry LP raised its stake in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company's stock valued at $60,000 after acquiring an additional 2,533 shares during the last quarter. Institutional investors own 94.48% of the company's stock.

Privia Health Group Stock Performance

Privia Health Group stock traded down $0.16 during mid-day trading on Monday, reaching $19.91. The stock had a trading volume of 392,217 shares, compared to its average volume of 841,445. Privia Health Group, Inc. has a fifty-two week low of $15.92 and a fifty-two week high of $24.30. The stock's 50-day simple moving average is $20.30 and its 200-day simple moving average is $19.16. The firm has a market capitalization of $2.39 billion, a PE ratio of 199.12, a price-to-earnings-growth ratio of 5.45 and a beta of 0.83.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on PRVA shares. Truist Financial increased their price objective on Privia Health Group from $24.00 to $27.00 and gave the company a "buy" rating in a report on Friday, November 8th. KeyCorp began coverage on Privia Health Group in a research note on Friday, October 11th. They issued an "overweight" rating and a $23.00 price objective on the stock. Macquarie initiated coverage on shares of Privia Health Group in a research report on Monday, December 16th. They set an "outperform" rating and a $25.00 target price for the company. Robert W. Baird boosted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an "outperform" rating in a research report on Monday, August 26th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a research report on Friday, November 29th. Two equities research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Buy" and a consensus target price of $24.80.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.